We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
- Authors
Herr, H W; Schwalb, D M; Zhang, Z F; Sogani, P C; Fair, W R; Whitmore, W F, Jr; Oettgen, H F
- Abstract
Superficial bladder tumors (stage Ta, T1, and Tis) may progress to invade the bladder muscle and cause death from metastatic cancer. Transurethral tumor resection (TURB) is the standard therapy for such tumors, but surgery alone may not prevent tumor progression. Intravesical therapy is widely used as an adjunct to TURB. Bacillus Calmette-Guérin (BCG) is the most active intravesical agent, but whether BCG prevents tumor progression and death from bladder cancer is unknown.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Vol 13, Issue 6, p1404
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1995.13.6.1404